The GZFD Clinical Research Study for Type 2 Diabetes and Excess Weight- USEThe GZFD Clinical Research Study for Type 2 Diabetes and Excess Weight- USE Facebook ad: “Type 2 Diabetes With Excess Weight + Semaglutide or…”
Ran for 14 days, from February 25 to March 11, 2026, the last day Crush saw it.
Run by The GZFD Clinical Research Study for Type 2 Diabetes and Excess Weight- USE on Facebook. Crush is not the advertiser and does not verify its claims. See this ad in Meta's Ad Library(opens in a new tab)
Want an ad like this for your product?
Crush makes new ad images for your product from this ad: your logo, your product photo, your offer.
Trials from $19.95 USD, then $79.95 USD a month. Cancel anytime.
About this ad
- Meta Ad Library ID
- 1288231403163866
- Platforms
- Facebook, Instagram and Messenger
- Relaunches
- 5
Ad text
A research study is seeking adults with type 2 diabetes and excess weight who are currently taking semaglutide or tirzepatide but need additional help reaching their blood sugar goals. Click to get started.
Where the ad sends people
lillyweightdiabetesstudies.com
Type 2 Diabetes With Excess Weight + Semaglutide or Tirzepatide Study
Impact the Future of Excess Weight, Diabetes, and Associated Conditions Answer the questions below to see if you may qualify for a research study now.
Learn more: lillyweightdiabetesstudies.com(opens in a new tab)
